SEC Form 4 · accession 0001437749-19-003425
MILESTONE SCIENTIFIC INC. · MLSS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Giandomenico Trombetta
Officer — See Remarks · Director
Period of report
Feb 8, 2019
Accepted (ET)
Feb 26, 2019 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855683
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001F1 | Feb 8, 2019 | P | 714,286 | $0.35 | A | 3,714,286 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants (right to buy)F2,F1 | $0.50 | Feb 8, 2019 | P | 178,571 | A | Feb 8, 2019 | Feb 8, 2024 | Common Stock | 178,571 | 178,571 | I |
Explanation of responses
- F1These securities are held directly by BP4 S.r.l. Innovest S.p.A. is the controlling shareholder of BP4 S.r.l. Mr. Trombetta is a shareholder and director of each of BP4 S.r.l. and Innovest S.p.A., and may be deemed to have voting and investment power over the securities held by BP4 S.r.l. Mr. Trombetta disclaims beneficial ownership of all securities held by BP4 S.r.l., except to the extent of his pecuniary interest therein, if any.
- F2$0.000001
Remarks
President & CEO of Issuer's dental division